The cardiac valvulotome market comprises medical devices that are used to cut and remove damaged heart valves. Cardiac valvulotomes help perform common cardiovascular procedures such as balloon valvuloplasty and heart valve repair. Some key product types include flexible valvulotomes, rigid valvulotomes, disposable valvulotomes, and cutting sheaths. Increasing demand for minimally invasive procedures and growing geriatric population suffering from valvular heart diseases are major drivers for this market.

The Global cardiac valvulotome market is estimated to be valued at US$ 157.2 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Cardiac Valvulotome Market Size  are LeMaitre, INVAMED, GeoSurgical, LimFlow, Inc., B. Braun SE, Teleflex Incorporated, StarFish Product Engineering Inc., Koven Technology Canada Inc., Andramed, Zgrum Medical, BD, PEAK SURGICAL, and Symmetry Surgical Inc. The rising incidence of cardiovascular diseases including rheumatic heart disease and calcific aortic stenosis has increased the demand for cardiac valvulotome procedures. Additionally, growing geriatric population who are more prone to developing valvular problems is also contributing to market growth. Major companies are expanding their product portfolios and presence globally especially in emerging regions of Asia Pacific and Latin America to tap the increasing opportunities.

Market drivers

One of the key drivers for the cardiac valvulotome market is the rising prevalence of cardiovascular diseases worldwide. Conditions such as valvular heart disease, coronary artery disease and rheumatic heart disease are becoming more common due to changing lifestyle diseases and increasing life expectancy. According to the World Health Organization, cardiovascular diseases account for over 17.9 million deaths annually across the globe. This increasing burden of heart conditions will significantly drive the need for cardiac valvulotome procedures and devices over the forecast period.

The current geopolitical situation is impacting the growth of the cardial valvulotome market. Political instability and economic uncertainties in various parts of the world are influencing healthcare spending and demand for different medical devices. The global supply chain disruptions due to the Russia-Ukraine conflict and trade tensions between some countries are posing challenges in the procurement of raw materials and components. This is hindering the production scale and output for key market players.

Moreover, economic sanctions imposed by different nations are restricting business opportunities in certain geographical locations. For sustained growth in the long run, companies need to diversify their manufacturing operations and supplier networks globally. They must also focus on innovating products that offer superior clinical outcomes to generate more demand even during difficult economic conditions. Developing versatile devices compatible with various interventional techniques can further boost the adoption rate.

Get more insights on Cardiac Valvulotome Market